We are live on ! Find out more
WA

Winfield Associates Portfolio holdings

AUM $276M
1-Year Est. Return 15.18%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+15.18%
3 Year Est. Return
+77.75%
5 Year Est. Return
+124.89%
10 Year Est. Return
AUM
$153M
AUM Growth
+$5.93M
Cap. Flow
+$3M
Cap. Flow %
1.96%
Top 10 Hldgs %
30.81%
Holding
810
New
97
Increased
202
Reduced
118
Closed
67

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.07%
2 Technology 7.48%
3 Communication Services 7.22%
4 Financials 4.86%
5 Industrials 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
226
Novo Nordisk
NVO
$220B
$27K 0.02%
1,020
+20
+2% +$548
RQI icon
227
Cohen & Steers Quality Income Realty Fund
RQI
$1.71B
$27K 0.02%
2,000
TROW icon
228
T. Rowe Price
TROW
$25.5B
$27K 0.02%
370
WEC icon
229
WEC Energy
WEC
$37.1B
$27K 0.02%
408
RDS.B
230
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$27K 0.02%
485
+155
+47% +$7.97K
BAC icon
231
Bank of America
BAC
$436B
$26K 0.02%
1,930
+900
+87% +$12.6K
EEM icon
232
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$26K 0.02%
750
WY.PRA
233
DELISTED
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
$26K 0.02%
507
HTBK
234
DELISTED
Heritage Commerce
HTBK
$25K 0.02%
2,392
TSM icon
235
TSMC
TSM
$2.07T
$25K 0.02%
940
+50
+6% +$1.25K
DE icon
236
Deere & Co
DE
$169B
$24K 0.02%
300
HON icon
237
Honeywell
HON
$77.9B
$24K 0.02%
229
+73
+47% +$7.5K
SNY icon
238
Sanofi
SNY
$105B
$24K 0.02%
570
-40
-7% -$1.64K
IONS icon
239
Ionis Pharmaceuticals
IONS
$9.25B
$23K 0.02%
1,000
-60
-6% -$1.94K
RY icon
240
Royal Bank of Canada
RY
$291B
$23K 0.02%
395
+5
+1% +$300
TMO icon
241
Thermo Fisher Scientific
TMO
$208B
$23K 0.02%
154
+134
+670% +$19.8K
DLR icon
242
Digital Realty Trust
DLR
$72.4B
$22K 0.01%
200
+190
+1,900% +$18K
ORCL icon
243
Oracle
ORCL
$345B
$22K 0.01%
540
VOD icon
244
Vodafone
VOD
$36.4B
$22K 0.01%
715
+5
+0.7% +$162
DHR icon
245
Danaher
DHR
$138B
$21K 0.01%
298
+194
+187% +$12.7K
UN
246
DELISTED
Unilever NV New York Registry Shares
UN
$21K 0.01%
445
+5
+1% +$224
ADP icon
247
Automatic Data Processing
ADP
$102B
$20K 0.01%
215
+75
+54% +$6.62K
AZN icon
248
AstraZeneca
AZN
$263B
$20K 0.01%
335
+5
+2% +$290
CPRI icon
249
Capri Holdings
CPRI
$1.82B
$20K 0.01%
399
NRK icon
250
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$904M
$20K 0.01%
1,400

Similar funds

Winfield Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Winfield Associates held 810 positions worth $153M, up 4% from $147M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Winfield Associates's Q2 2016 filing shows 97 new, 202 increased, 118 reduced and 67 closed positions. Its largest new stake was Arista Networks: 85,600 shares worth $344K. The largest sale was WisdomTree Europe Hedged Equity Fund, an estimated $1.02M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.1% of assets, down from 8.1% a quarter earlier, followed by Technology and Communication Services.

  • Winfield Associates's largest Q2 2016 buy was Arista Networks: 85,600 shares worth $344K.
  • Winfield Associates added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2016, an estimated $1.52M increase.
  • Winfield Associates's biggest Q2 2016 reduction was Rite Aid Corporation, cutting an estimated $740K.
  • Winfield Associates fully exited WisdomTree Europe Hedged Equity Fund in Q2 2016, selling an estimated $1.02M.
  • Winfield Associates's ten largest holdings make up 31% of its $153M portfolio in Q2 2016.
  • Winfield Associates opened 97 new positions and closed 67 in Q2 2016.
  • Winfield Associates's portfolio value rose 4% quarter-over-quarter to $153M.

Based on Winfield Associates's 13F filing for Q2 2016, filed 15 Aug 2016.